» Articles » PMID: 35701780

Network Pharmacology and Molecular Docking Approach to Elucidate the Mechanisms of Liuwei Dihuang Pill in Diabetic Osteoporosis

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2022 Jun 14
PMID 35701780
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetic osteoporosis (DOP) is one of the chronic complications of diabetes mellitus, but without a standardized treatment plan till now. Liuwei Dihuang pill (LDP) has gradually exerted a remarkable effect on DOP in recent years; its specific mechanism is not clear yet.

Methods: We adopted network pharmacology approaches, including multi-database search, pharmacokinetic screening, network construction analysis, gene ontology enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway analysis and molecular docking to elaborate the active components, signaling pathways and potential mechanisms of LDP in the treatment of DOP.

Results: Twenty-seven active ingredients and 55 related disease targets have been found through integrated network pharmacology. Functional enrichment analysis shows that five key active ingredients, including beta-sitosterol, stigmasterol, diosgenin, tetrahydroalstonine, and kadsurenone, may give full scope to insulin secretion estrogen-level raising and angiogenesis in biological process through the pivotal targets. In addition, the underlying effect of PI3K/AKT/FOXO and VEGF pathways is also suggested in the treatment.

Conclusion: Based on systematic network pharmacology methods, we predicted the basic pharmacological effects and potential mechanisms of LDP in the treatment of DOP, revealing that LDP may treat DOP through multiple targets and multiple signaling pathways, which provide evidence for the further study of pharmacological mechanism and broader clinical thinking.

Citing Articles

Epimedium brevicornum Maxim alleviates diabetes osteoporosis by regulating AGE-RAGE signaling pathway.

Lei S, Wang Y, Huang X, Wang X, Gao M, Li B Mol Med. 2025; 31(1):101.

PMID: 40089686 DOI: 10.1186/s10020-025-01152-2.


A Systematic Review of the Phytochemical Profile and Potential Medicinal Functions of in Cancer.

Fan H, Ren C, Feng Y, Zhu L, Yu A, Guan T Food Sci Nutr. 2025; 13(3):e70054.

PMID: 40008240 PMC: 11848418. DOI: 10.1002/fsn3.70054.


Network Pharmacology and Experimental Validation of the Therapeutic Effect of Baji Capsule on LPS-Induced Osteoporosis.

Li Q, Li D, Tian C, Liu X, Wang H, Liu H Orthop Res Rev. 2025; 17:61-81.

PMID: 39958436 PMC: 11829595. DOI: 10.2147/ORR.S488478.


Using network pharmacology and molecular docking technology, proteomics and experiments were used to verify the effect of Yigu decoction (YGD) on the expression of key genes in osteoporotic mice.

Yan K, Zhang R, Wang J, Chen H, Zhang Y, Cheng F Ann Med. 2025; 57(1):2449225.

PMID: 39749683 PMC: 11703118. DOI: 10.1080/07853890.2024.2449225.


Based on network pharmacology and molecular docking to explore the potential mechanism of shikonin in periodontitis.

Zhao Q, Wang K, Hou L, Guo L, Liu X BMC Oral Health. 2024; 24(1):839.

PMID: 39048977 PMC: 11270799. DOI: 10.1186/s12903-024-04618-7.


References
1.
Cheng X, Qi C, Wang T, Zhou W, Zhang Y . Characteristics of the traditional Liu-Wei-Di-Huang prescription reassessed in modern pharmacology. Chin J Nat Med. 2019; 17(2):103-121. DOI: 10.1016/S1875-5364(19)30013-5. View

2.
Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D . GeneCards: integrating information about genes, proteins and diseases. Trends Genet. 1997; 13(4):163. DOI: 10.1016/s0168-9525(97)01103-7. View

3.
Oikawa A, Siragusa M, Quaini F, Mangialardi G, Katare R, Caporali A . Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol. 2010; 30(3):498-508. PMC: 3548136. DOI: 10.1161/ATVBAHA.109.200154. View

4.
Uemura T, Hirai S, Mizoguchi N, Goto T, Lee J, Taketani K . Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol Nutr Food Res. 2010; 54(11):1596-608. DOI: 10.1002/mnfr.200900609. View

5.
Sergi C, Shen F, Liu S . Insulin/IGF-1R, SIRT1, and FOXOs Pathways-An Intriguing Interaction Platform for Bone and Osteosarcoma. Front Endocrinol (Lausanne). 2019; 10:93. PMC: 6405434. DOI: 10.3389/fendo.2019.00093. View